Skip to main content
Premium Trial:

Request an Annual Quote

Atila Biosystems Gets FDA Emergency Use Authorization for SARS-CoV-2 Test

NEW YORK – The US Food and Drug Administration on Friday granted Emergency Use Authorization for Atila Biosystems' SARS-CoV-2 test.

The iAMP COVID-19 Detection Kit, a qualitative real-time RT-PCR test, detects SARS-CoV-2 in nasal, nasopharyngeal, and oropharyngeal swabs. The kit includes the company's primer mix, buffer mix, positive and negative control templates, and the sample collection device, which has fiber swabs, collection tubes, and buffer mix.

According to the Mountain View, California-based company, the test is unique because it can detect SARS-CoV-2 RNA directly from samples without a prior RNA extraction process. The test takes less than two hours for results, the company added. 

Use of the test is limited to high-complexity CLIA-certified labs, the FDA said.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.